Legal wrangling is complicating life for those who want to use [CRISPR technology] to develop commercial products.
…
At issue is the fact that the patent landscape for CRISPR-Cas9 is likely to remain complicated and dynamic for years to come, as more patent applications are examined, granted, opposed or revoked in different jurisdictions. The outcome of these patent disputes could have a major impact on the innovation and commercialization of CRISPR-Cas9, as well as on the public interest and social responsibility of using this powerful technology.
However, the ownership and licensing of this technology is also a source of legal disputes and controversies among various parties. Anyone who thought gene editing would level the playing field and open a world of new breeding possibilities free from the high costs of working in the GM space might want to think again, thanks to the complicated world of gene editing patents.

























